ABSTRACT
Purpose
To explore hot melt extrusion (HME) as a scalable, solvent-free, continuous technology to design cocrystals in agglomerated form.
Methods
Cocrystal agglomerates of ibuprofen and nicotinamide in 1:1 ratio were produced using HME at different barrel temperature profiles, screw speeds, and screw configurations. Product was characterized for crystallinity by XRPD and DSC, while the morphology was determined by SEM. Dissolution rate and tabletting properties were compared with ibuprofen.
Results
Process parameters significantly affected the extent of cocrystallization which improved with temperature, applied shear and residence time. Processing above eutectic point was required for cocrystallization to occur, and it improved with mixing intensity by changing screw configuration. Product was in the form of spherical agglomerates, which showed directly compressible nature with enhanced dissolution rate compared to ibuprofen. This marks an important advantage over the conventional techniques, as it negates the need for further size modification steps.
Conclusions
A single-step, scalable, solvent-free, continuous cocrystallization and agglomeration technology was developed using HME, offering flexibility for tailoring the cocrystal purity. HME being an established technology readily addresses the regulatory demand of quality by design (QbD) and process analytical technology (PAT), offering high potential for pharmaceuticals.
Similar content being viewed by others
Abbreviations
- DSC:
-
differential scanning calorimetry
- HME:
-
hot melt extrusion
- Ibu-Nic cocrystal:
-
ibuprofen-nicotinamide 1:1 cocrystal
- NIR:
-
near infra red
- PAT:
-
process analytical technology
- PM:
-
physical mixture of ibuprofen and nicotinamide
- Py:
-
mean yield pressure
- QbD:
-
quality by design
- SEM:
-
scanning electron microscopy
- XRPD:
-
X-ray powder diffractometry
REFERENCES
Trask AV, Motherwell WD, Jones W. Physical stability enhancement of theophylline via cocrystallization. Int J Pharm. 2006;320:114–23.
Aakeroy CB, Forbes S, Desper J. Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug. J Am Chem Soc. 2009;131:17048–9.
Good DJ, Rodriguez-Hornedo N. Solubility advantage of pharmaceutical cocrystals. Cryst Growth Des. 2009;9:2252–64.
Remenar JF, Morissette SL, Peterson ML, Moulton B, MacPhee JM, Guzman HR, et al. Crystal engineering of novel cocrystals of a triazole drug with 1, 4-dicarboxylic acids. J Am Chem Soc. 2003;125:8456–7.
McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, et al. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res. 2006;23:1888–97.
Karki S, Friscic T, Laszlo F, Laity PR, Day GM, Jones W. Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol. Adv Mater. 2009;21:3905–9.
Sun CC, Hou H. Improving mechanical properties of caffeine and methyl gallate crystals by cocrystallization. Cryst Growth Des. 2008;8:1575–9.
Weyna DR, Shattock T, Vishweshwar P, Zaworotko MJ. Synthesis and structural characterization of cocrystals and pharmaceutical cocrystals: mechanochemistry vs slow evaporation from solution. Cryst Growth Des. 2009;9:1106–23.
Hickey MB, Peterson ML, Scoppettuolo LA, Morrisette SL, Vetter A, Guzmán H, et al. Performance comparison of a co-crystal of carbamazepine with marketed product. Eur J Pharm Biopharm. 2007;67:112–9.
Trask AV, van de Streek J, Motherwell WDS, Jones W. Achieving polymorphic and stoichiometric diversity in cocrystal formation: importance of solid-state grinding, powder x-ray structure determination, and seeding. Cryst Growth Des. 2005;5:2233–41.
Trask AV, Motherwell WDS, Jones W. Pharmaceutical cocrystallization: engineering a remedy for caffeine hydration. Cryst Growth Des. 2005;5:1013–21.
Takata N, Shiraki K, Takano R, Hayashi Y, Terada K. Cocrystal screening of stanolone and mestanolone using slurry crystallization. Cryst Growth Des. 2008;8:3032–7.
Childs SL, Mougin P. Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound. WO. 2005;089375:A2.
Aher S, Dhumal RS, Mahadik KR, Paradkar AR, York P. Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: caffeine/maleic acid. Eur J Pharm Sci. 2010;In Press, Accepted manuscript. doi:10.1016/j.ejps.2010.08.012.
Kuroda R, Imai Y, Tajima N. Generation of a co-crystal phase with novel coloristic properties via solid state grinding procedures. Chem Commun (Camb). 2002;23:2848–9.
Rastogi RP, Bassi PS, Chadha SL. Mechanism of the reaction between hydrocarbons and picric acid in the solid state. J Phys Chem. 1963;67:2569–73.
Rothenberg G, Downie AP, Raston CL, Scott JL. Understanding solid/solid organic reactions. J Am Chem Soc. 2001;123:8701–8.
Chadwick K, Davey R, Cross W. How does grinding produce co-crystals? Insights from the case of benzophenone and diphenylamine. Cryst Eng Comm. 2007;9:732–4.
Shan N, Toda F, Jones W. Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics. Chem Commun. 2002;20:2372–3.
Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 2009;9:2950–67.
Sheikh AY, Rahim SA, Hammond RB, Roberts KJ. Scalable solution cocrystallization: case of carbamazepine-nicotinamide I. Cryst Eng Comm. 2009;11:501–9.
Mazen H, Townend N. Method of creating crystalline substances. US. 2008;0280858:A1.
Padrela L, Rodrigues MA, Velaga SP, Fernandes AC, Matos HA, de Azevedo EG. Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process. J Supercrit Fluid. 2010;53:156–64.
Paradkar AR, Kelly AL, Coates PD, York P. Method and product. WO. 2010;013035:A1.
Medina C, Daurio D, Nagapudi K, Alvarez-Nunez F. Manufacture of pharmaceutical co-crystals using twin screw extrusion: a solvent-less and scalable process. J Pharm Sci. 2010;99:1693–6.
Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK, et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm. 2007;33:909–26.
Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F, et al. Pharmaceutical applications of hot-melt extrusion: part II. Drug Dev Ind Pharm. 2007;33:1043–57.
Berry DJ, Seaton CC, Clegg W, Harrington RW, Coles SJ, Horton PN, et al. Applying hot-stage microscopy to co-crystal screening: a study of nicotinamide with seven active pharmaceutical ingredients. Cryst Growth Des. 2008;8:1697–712.
Lu E, Rodriguez-Hornedo N, Suryanarayanan R. A rapid thermal method for cocrystal screening. Cryst Eng Comm. 2008;10:665–8.
Melo TFA, Canevarolo SV. An optical device to measure in-line residence time distribution curves during extrusion. Poly Eng Sci. 2002;42:170–81.
Wostheinrich K, Schmidt PC. Polymorphic changes of thiamine hydrochloride during granulation and tableting. Drug Dev Ind Pharm. 2001;27:481–9.
Sun C, Grant D. Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: a molecular insight. Pharm Res. 2004;21:382–6.
Maheshwari M, Ketkar AR, Chauhan B, Patil VB, Paradkar AR. Preparation and characterization of ibuprofen-cetyl alcohol beads by melt solidification technique: effect of variables. Int J Pharm. 2003;261:57–67.
Dhumal RS, Shimpi SL, Chauhan B, Mahadik KR, Paradkar AR. Evaluation of a drug with wax-like properties as a melt binder. Acta Pharm. 2006;56:451–61.
Romero AJ, Grady LT, Rhodes CT. Dissolution testing of ibuprofen tablets. Drug Dev Ind Pharm. 1988;14:1549–86.
Stead JA, Freeman M, John EG, Ward GT, Whiting B. Ibuprofen tablets: dissolution and bioavailability studies. Int J Pharm. 1983;14:59–72.
Oberoi LM, Alexander KS, Riga AT. Study of interaction between ibuprofen and nicotinamide using differential scanning calorimetry, spectroscopy, and microscopy and formulation of a fast-acting and possibly better ibuprofen suspension for osteoarthritis patients. J Pharm Sci. 2005;94:93–101.
Van Melkebeke B, Vermeulen B, Vervaet C, Remon JP. Melt granulation using a twin-screw extruder: a case study. Int J Pharm. 2006;326:89–93.
ACKNOWLEDGEMENTS
Yorkshire Concept, Proof of Concept Funding, Yorkshire Forward, UK. The authors gratefully acknowledge the technical assistance of Andy Baker, Thermo Scientific, UK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dhumal, R.S., Kelly, A.L., York, P. et al. Cocrystalization and Simultaneous Agglomeration Using Hot Melt Extrusion. Pharm Res 27, 2725–2733 (2010). https://doi.org/10.1007/s11095-010-0273-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-010-0273-9